Evotec
EVO
21 hedge funds and large institutions have $38.9M invested in Evotec in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
0.2% less ownership
Funds ownership: 1.6% → 1.4% (-0.2%)
25% less funds holding
Funds holding: 28 → 21 (-7)
42% less capital invested
Capital invested by funds: $66.5M → $38.9M (-$27.6M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$345K |
| 2 |
BlackRock
New York
|
+$200K |
| 3 |
CA
Cetera Advisors
Denver,
Colorado
|
+$189K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$60.6K |
| 5 |
QCG
Quadrant Capital Group
Cincinnati,
Ohio
|
+$32.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.74M |
| 2 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$2.04M |
| 3 |
Optiver Holding
Amsterdam,
Netherlands
|
-$309K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$141K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$35K |
EVO Hedge Fund Activity: Q1 2024 in Review
21 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Evotec (EVO) for Q1 2024, worth a combined $38.9M — down 42% from $66.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of EVO and 3 opened new positions — a net loss of 7 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Morgan Stanley, adding an estimated $345K. The largest seller was Federated Hermes, exiting entirely with an estimated $6.74M sold.
- 21 institutional investors held Evotec (EVO) as of Q1 2024, down from 28 in Q4 2023.
- Funds reported $38.9M of Evotec stock for Q1 2024, down 42% quarter-over-quarter.
- 3 funds opened new Evotec positions in Q1 2024 and 10 closed out, a net change of -7 holders.
- The largest Evotec buyer in Q1 2024 was Morgan Stanley, an estimated $345K added.
- The largest Evotec seller in Q1 2024 was Federated Hermes, an estimated $6.74M sold.
Based on aggregated 13F filings for Q1 2024.